Reviewed Mar 2026 | PubMed sources
Active Market
This comparison can feed directly into US-first legal, provider, and cost workflows.

Sermorelin vs GHRP-2: Head-to-Head Comparison

Sermorelin (GHRH pathway) and GHRP-2 (ghrelin pathway) stimulate GH through different receptor systems. Sermorelin has a longer clinical history with former FDA approval, while GHRP-2 provides a stronger acute GH pulse. They are often combined for synergistic GH release.

Approved Comparison Routing

Approved options in this comparison

A
Sermorelin

Sermorelin is currently modeled on this site as an approved treatment path for: Diagnosis and treatment of growth hormone deficiency in children. Brand names in the current dataset: Geref.

Validation note: This block reflects the site's current structured treatment data and internal routing logic. It does not replace checking current labeling, payer rules, or local prescribing conditions.

Want to discuss Sermorelin with a provider?

Sermorelin is currently modeled on this site as an approved treatment path. Use the provider matcher to narrow fit by state, insurance, budget, and urgency.

Find a provider

Side-by-Side Comparison

DimensionSermorelinGHRP-2
Evidence LevelFormerly FDA-approved; extensive clinical dataExtensive clinical research
FDA StatusPreviously FDA-approvedNot approved
MechanismGHRH receptor agonistGhrelin receptor (GHS-R1a) agonist
GH Release PatternPhysiological pulsatile releaseStrong acute GH pulse
Side EffectsFlushing, headache, injection site painHunger, cortisol/prolactin increase
Half-Life~10-20 minutes~15-60 minutes
Evidence Level
Sermorelin
Formerly FDA-approved; extensive clinical data
GHRP-2
Extensive clinical research
FDA Status
Sermorelin
Previously FDA-approved
GHRP-2
Not approved
Mechanism
Sermorelin
GHRH receptor agonist
GHRP-2
Ghrelin receptor (GHS-R1a) agonist
GH Release Pattern
Sermorelin
Physiological pulsatile release
GHRP-2
Strong acute GH pulse
Side Effects
Sermorelin
Flushing, headache, injection site pain
GHRP-2
Hunger, cortisol/prolactin increase
Half-Life
Sermorelin
~10-20 minutes
GHRP-2
~15-60 minutes

Peptide Overviews

Sermorelin

AFDA Approved

Sermorelin is the shortest fully functional fragment of GHRH (amino acids 1-29). It was the first GHRH analog approved by the FDA, marketed as Geref for diagnostic and therapeutic use. Geref was subsequently discontinued in the U.S. market, though sermorelin remains available through compounding pharmacies. Geref was subsequently discontinued in the U.S. market, though sermorelin remains available through compounding pharmacies.

Growth Hormone SecretagoguesFDA Approved
View full Sermorelin profile →

GHRP-2

BHuman Studies

GHRP-2 is a synthetic hexapeptide growth hormone secretagogue. It is one of the most potent GHRPs and has been used in clinical research for GH deficiency diagnosis.

Growth Hormone SecretagoguesNot Approved
View full GHRP-2 profile →

GLP-1 Support Essentials

Products that can support side-effect management, hydration, and protein intake.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Sermorelin vs GHRP-2: FAQ